More than half of patients with chronic pain conditions meet diagnostic criteria for a co-occurring mood disorder — and more than half of patients with major depressive disorder report significant physical pain as a feature of their condition — yet the standard healthcare system consistently treats these two presentations as separate problems that belong to separate specialists. For patients in Toledo and northwest Ohio who live at the intersection of chronic pain and depression, this fragmented approach means half of the problem is managed at best. At Awakenings by Northwest Ohio Ketamine, our multidisciplinary clinical team was built specifically to treat both conditions simultaneously, within a single coordinated care model.
Why Chronic Pain and Depression Overlap
Chronic pain and depression are not simply comorbid conditions that happen to occur together by coincidence — they share overlapping neurobiological mechanisms that make each condition worse in the presence of the other. Both conditions involve dysregulation of central sensitization pathways in which the central nervous system becomes amplified in its response to input — whether that input is painful stimuli or negative emotional experience. Both involve alterations in HPA axis function, inflammatory signaling, and monoamine neurotransmitter systems including serotonin and norepinephrine. Both are associated with disruptions in sleep architecture, cognitive function, and the subjective sense of having a future.
The NMDA receptor, which plays a central role in how ketamine exerts its effects, is directly involved in both central sensitization in chronic pain and in the synaptic dysfunction associated with depression. Central sensitization — the process by which the nervous system becomes abnormally sensitized to pain signals — is now recognized as a core mechanism in fibromyalgia, chronic regional pain syndrome (CRPS), and migraine, among other conditions. In these conditions, the pain is not primarily a peripheral tissue injury problem; it is a nervous system calibration problem. Depression produces similar changes in how the nervous system processes and amplifies negative inputs. This shared biology is not incidental — it has direct clinical implications for how treatment should be designed.
Research published in Pain has found that patients with both chronic pain and depression have significantly worse outcomes on both dimensions when compared to patients with either condition alone — and that interventions targeting only one condition produce weaker and shorter-lasting improvements than those that address both simultaneously (Bair et al., 2003). This is exactly the problem that our clinical team at Awakenings was structured to solve.
How Awakenings Approaches Co-Occurring Pain and Depression
The team at Awakenings by Northwest Ohio Ketamine is deliberately multidisciplinary. Dr. William James, MD, brings deep clinical expertise in anesthesiology — the medical discipline that encompasses the pharmacological management of pain at the highest level of training — as well as specific experience with ketamine’s role in pain management. Dr. Nadeem Moghal completed his fellowship at the Cleveland Clinic Foundation Pain Management Center, one of the nation’s leading institutions in the management of complex chronic pain. Ben Wagner, PMHNP-BC, is a board-certified Psychiatric Mental Health Nurse Practitioner who brings the psychiatric perspective to the team — assessing mood, trauma history, cognitive function, and the psychological dimensions of pain experience.
This structure matters because pain and depression present differently in the same patient, and addressing them well requires both lenses applied simultaneously. A patient with fibromyalgia and depression does not benefit from having their depression treated in a psychiatrist’s office while their pain is separately managed by a pain specialist who never speaks with the psychiatrist. They benefit from a team that sees the full picture at once. At Awakenings, every patient is assessed across both the pain and mental health dimensions, and the care plan reflects that integrated understanding.
IV ketamine is the clinical centerpiece of our treatment for patients with co-occurring chronic pain and depression. As an off-label treatment for both conditions, ketamine’s dual mechanism — antagonizing NMDA receptors that drive both central sensitization and synaptic dysfunction — makes it uniquely suited to patients who carry both diagnoses. Ketamine has been used in anesthesia and pain management for decades, and its application to complex chronic pain conditions is an extension of that established pharmacological tradition rather than a departure from it. For patients with CRPS, fibromyalgia, or chronic migraine alongside mood disorders, IV ketamine addresses a biological underpinning that most other treatments approach only partially.
Supporting the Whole Person Beyond Infusions
IV ketamine is an important treatment tool, but it functions best within a broader holistic wellness framework that addresses the full range of factors contributing to chronic pain and depression. At Awakenings, we pair ketamine with additional services designed to support the cellular, nutritional, and psychological dimensions of recovery.
NAD+ therapy supports mitochondrial function and cellular energy production — relevant to both chronic pain (in which mitochondrial dysfunction has been documented in several conditions) and to depression (in which neuronal energy demands are high and mitochondrial impairment has been observed). We often include NAD+ therapy as part of the treatment protocol for patients managing both chronic pain and depression, as it addresses a cellular dimension that ketamine does not directly target.
Vitamin infusions — including magnesium, which has both analgesic and anxiolytic properties, and B vitamins essential to neurotransmitter synthesis — provide targeted nutritional support that many patients with chronic conditions are deficient in, often as a result of the systemic metabolic demands of sustained pain and stress. Holistic wellness planning and integration coaching help patients build the lifestyle, psychological, and behavioral foundations that sustain improvement beyond the infusion room. Results vary by individual, and we tailor every aspect of the care plan to your specific clinical situation.
Addressing Barriers Specific to This Population
Patients with co-occurring chronic pain and depression often carry a heavy burden of prior healthcare experiences — multiple providers, conflicting explanations, treatments that worked partially or not at all, and sometimes outright dismissal of the legitimacy of their pain. This history appropriately generates caution when approaching a new provider. We want patients to know that our team takes both conditions seriously, and that the clinical composition of Awakenings — with fellowship-trained pain management expertise and board-certified psychiatric expertise under the same roof — reflects a specific commitment to treating this population as their complexity deserves.
Transportation and mobility can also be genuine barriers for patients with chronic pain who have difficulty traveling. We encourage prospective patients to contact us before assuming that logistical barriers make treatment impossible. We work to find solutions where possible and to accommodate the practical realities of patients managing significant chronic conditions. Discuss with your provider before your first visit what accommodations or scheduling approaches might help. Understanding chronic pain symptoms in depth can also help you communicate your needs more clearly when you arrive.
Frequently Asked Questions
Does IV ketamine treat pain the same way it treats depression?
IV ketamine targets NMDA receptor-mediated central sensitization — the mechanism underlying many chronic pain conditions — and also produces synaptic renewal effects relevant to depression. These are related but distinct effects of the same pharmacological mechanism. The dosing protocols used at Awakenings are calibrated based on your primary clinical presentation, whether that is pain, mood, or both.
What chronic pain conditions does Awakenings treat?
Our team treats a range of chronic pain conditions including fibromyalgia, chronic regional pain syndrome (CRPS), migraine, and chronic neuropathic conditions. Dr. Moghal’s fellowship training at the Cleveland Clinic Foundation Pain Management Center and Dr. James’s anesthesiology background provide the foundation for complex pain management that not all ketamine clinics can offer.
Can IV ketamine help with fibromyalgia?
Fibromyalgia is a chronic pain condition characterized by central sensitization — heightened nervous system sensitivity to stimuli — that is directly targeted by ketamine’s NMDA receptor mechanism. Off-label use of IV ketamine for fibromyalgia has been explored in clinical studies with promising early results, though the evidence base is less mature than for depression. We discuss the current evidence honestly with every patient during their consultation.
What if I have been told my pain is psychological?
The mind-body division in medicine is outdated. Chronic pain involves real neurobiological changes — measurable and documented — and the psychological experience of pain is not evidence that the pain is “made up.” At Awakenings, we evaluate and treat the whole person, including both the neurological and psychological dimensions of pain. You will not be dismissed here.
Is ketamine for chronic pain covered by insurance?
IV ketamine for chronic pain conditions is generally not covered by commercial insurance for most indications, similar to its psychiatric applications. At Awakenings, we provide transparent pricing so you understand the financial commitment before proceeding. We recommend discussing your specific situation with our team during your initial consultation.
Key Takeaways
- Chronic pain and depression share overlapping neurobiological mechanisms — including central sensitization, NMDA receptor dysregulation, and HPA axis disruption — which explains why they so often co-occur and worsen each other.
- At Awakenings by Northwest Ohio Ketamine in Toledo, a multidisciplinary team including an anesthesiologist, a fellowship-trained pain specialist, and a psychiatric NP is designed specifically to treat both conditions within a single care model.
- IV ketamine addresses central sensitization (the mechanism underlying many chronic pain conditions) and synaptic dysfunction (the mechanism underlying depression) through the same NMDA receptor pathway.
- Holistic care at Awakenings includes NAD+ therapy, vitamin infusions, and integration coaching to support the cellular, nutritional, and psychological dimensions of recovery alongside ketamine treatment.
- Results vary by individual; IV ketamine is off-label for both psychiatric and chronic pain indications. Discuss with your provider whether this approach is appropriate for your specific clinical situation.
If you are managing both chronic pain and depression in Toledo or northwest Ohio and have not found a care model that addresses the full picture, Awakenings by Northwest Ohio Ketamine was built for you. Schedule a consultation with our team today.
About Dr. William James, MD
Dr. William James, MD, leads Awakenings by Northwest Ohio Ketamine in Toledo, OH, bringing a clinical background spanning anesthesiology and pain management to the treatment of chronic pain and mood disorders. The clinical team also includes Dr. Nadeem Moghal, who completed a fellowship at the Cleveland Clinic Foundation Pain Management Center, and Ben Wagner, PMHNP-BC, a board-certified Psychiatric Mental Health Nurse Practitioner — a multidisciplinary composition specifically designed to hold the pain, mood, cognitive, and functional dimensions of each patient’s condition in view simultaneously. Together, they approach chronic pain as a whole-person condition, integrating anesthesiology expertise with behavioral health in a way that most single-specialty practices cannot.
References
Bair, M. J., et al. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/14610012/
Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain. https://pubmed.ncbi.nlm.nih.gov/21144659/
Dworkin, R. H., et al. (2008). Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Archives of Neurology. https://pubmed.ncbi.nlm.nih.gov/14610012/
American Chronic Pain Association. https://theacpa.org/
Medical Disclaimer
The information in this blog post is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. IV ketamine and other infusion therapies described are off-label uses or clinician-supervised wellness treatments. Individual results vary. All treatments should be evaluated by a qualified healthcare provider based on your complete medical history. If you are experiencing a pain or mental health crisis, please seek immediate medical attention.